LLY vs JNJ
By Alex · Tickerpine
Eli Lilly and Company vs Johnson & Johnson, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,220.28 | $260.86 |
| Market cap | $1.09T | $628.65B |
| P/E ratio | 41.0 | 30.3 |
| ROE | 102.29% | 25.74% |
| Profit margin | 33.53% | 21.48% |
| Revenue growth | 47.70% | 6.60% |
| Dividend yield | 0.57% | 2.05% |
| Beta | 0.51 | 0.23 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs JNJ in plain English
- LLY is the bigger company — about 1.7× the market cap of JNJ.
- JNJ is cheaper on earnings (P/E 30.3 vs 41.0).
- LLY earns a higher return on equity (102% vs 26%).
- LLY is growing revenue faster (48% vs 7%).
- JNJ has the higher dividend yield (2.05% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.